The cardiac literature suggests that approximately 30% of patients are resistant to Plavix. Multiple studies have suggested that an inappropriate response to Plavix is related to increased risk of ...
Introduction Endovascular aneurysm treatment by flow diversion has classically relied on dual anti-platelet therapy with Aspirin and Plavix to reduce thrombotic complications. The heterogenous Plavix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback